{"name": "Antegrin Therapeutics",
 "permalink": "antegrin-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/antegrin-therapeutics",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2012,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "small-molecule, pulmonary-fibrosis",
 "alias_list": null,
 "email_address": "",
 "phone_number": "",
 "description": "small molecule integrin antagonists",
 "created_at": "Tue Jun 04 17:07:45 UTC 2013",
 "updated_at": "Wed Jun 05 18:32:26 UTC 2013",
 "overview": "\u003Cp\u003EAntegrin seeks to develop small molecule integrin antagonists for use in multiple disease states. The founders have developed early-stage lead compounds, and the company seeks to license the intellectual property surrounding these compounds from St. Louis University, synthesize additional compounds and identify compounds that can be advanced into clinical trials.  The lead indication is currently idiopathic pulmonary fibrosis, a life-threatening condition with no approved medicines. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       50],
      "assets/images/resized/0027/1188/271188v2-max-150x150.png"],
     [[250,
       83],
      "assets/images/resized/0027/1188/271188v2-max-250x250.png"],
     [[270,
       90],
      "assets/images/resized/0027/1188/271188v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "seed",
    "source_url": "http://www.bizjournals.com/stlouis/blog/BizNext/2013/04/biogenerator-closes-investment-on.html",
    "source_description": "St. Louis Business Journal",
    "raised_amount": null,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 2,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "BioGenerator",
         "permalink": "biogenerator",
         "image":
          {"available_sizes":
            [[[150,
               101],
              "assets/images/resized/0012/0644/120644v3-max-150x150.jpg"],
             [[215,
               146],
              "assets/images/resized/0012/0644/120644v3-max-250x250.jpg"],
             [[215,
               146],
              "assets/images/resized/0012/0644/120644v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "4320 Forest Park Ave.",
    "address2": "",
    "zip_code": "63108",
    "city": "St. Louis",
    "state_code": "MO",
    "country_code": "USA",
    "latitude": 38.6368811,
    "longitude": -90.2528056}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}